2025-10-05 - Analysis Report
Okay, here's an analysis of Intuitive Surgical Inc. (ISRG) based on the provided data.

**Report on Intuitive Surgical Inc. (ISRG)**

Intuitive Surgical Inc. designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

**1. Performance vs. S&P 500 (VOO)**

*   **ISRG Cumulative Return:** 68.50%
*   **VOO Cumulative Return:** 98.51%
*   **Absolute Deviation:** -33.51%
*   **Relative Deviation:** 1.2 (Indicates ISRG's performance is near the minimum end of its historical deviation range from VOO)

**Analysis:**

ISRG has underperformed the S&P 500 (VOO) over the period examined. The relative deviation suggests that this underperformance is near the historical worst-case scenario compared to VOO.
*Note: The absolute deviation is calculated as ISRG Cumulative Return - VOO Cumulative Return*

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha  | Beta | Cap(B) |
|------------|--------|--------|--------|------|--------|
| 2015-2017  | 68.0%  | 77.6%  | 40.0%  | -0.1 | 43.6   |
| 2016-2018  | 64.0%  | 72.2%  | 49.0%  | -0.0 | 57.2   |
| 2017-2019  | 54.0%  | 72.2%  | 31.0%  | 0.2  | 70.6   |
| 2018-2020  | -6.0%  | 80.4%  | -29.0% | 0.3  | 97.8   |
| 2019-2021  | 29.0%  | 80.4%  | -18.0% | 0.6  | 128.8  |
| 2020-2022  | -23.0% | 80.4%  | -22.0% | 1.2  | 95.1   |
| 2021-2023  | -17.0% | 77.5%  | -18.0% | 1.7  | 120.9  |
| 2022-2024  | 36.0%  | 77.5%  | 15.0%  | 1.7  | 187.1  |
| 2023-2025  | 31.0%  | 72.7%  | -32.0% | 0.8  | 162.2  |

**Analysis:**

*   **CAGR:** Fluctuating CAGR, with negative values in 2018-2020, 2020-2022, and 2021-2023. The most recent CAGR (2023-2025) is 31.0%.
*   **MDD:** Consistently high Maximum Drawdown (MDD), indicating significant potential for losses.
*   **Alpha:** Alpha has varied, with generally positive Alpha values until 2017-2019, after which most periods show negative Alpha, indicating underperformance relative to its benchmark.
*   **Beta:** Beta has increased over time. A Beta > 1 in recent periods (2020-2022, 2021-2023, 2022-2024) indicates higher volatility than the market.
*   **Cap(B):** Market capitalization has generally increased over time, although there have been periods of decline.

**2. Recent Stock Price Movement**

*   **Current Price:** 452.35
*   **Previous Close:** 443.01
*   **Change:** 2.11%
*   **5-day Moving Average:** 445.03
*   **20-day Moving Average:** 445.65
*   **60-day Moving Average:** 471.57

**Analysis:**

The stock price is above the 5-day and 20-day moving averages, but below the 60-day moving average. This suggests a possible short-term upward trend but longer-term resistance. The 2.11% increase from the previous close suggests positive momentum.

**3. Market Risk Indicator (MRI) and Other Indicators**

*   **MRI:** 0.9 (High Investment Recommended)
*   **RSI:** 64.61 (Approaching overbought territory)
*   **PPO:** 0.47
*   **Hybrid Signal:** Cash_0%_Buy 100% of cash (2 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00)
*   **Delta_Previous_Relative_Divergence:** -0.2 (Short-term decrease)
*   **Expected Return (%):** 1046.1%

**Analysis:**

*   **MRI:** A high MRI score suggests the stock is currently perceived as having relatively low risk.
*   **RSI:** The RSI is approaching overbought levels, which could indicate a potential pullback in the near term.
*   **Delta_Previous_Relative_Divergence:** The short-term decrease in relative divergence suggests a recent downward trend.
*   **Expected Return:** The extremely high expected return suggests significant potential upside over a long-term investment horizon, outperforming the S&P 500.
*   **Price Change:** The recent price change is relatively high, suggesting a potential rapid increase, possibly due to recent news or market sentiment.

**4. Recent News & Significant Events**

*   **Positive Sentiment:** Several articles highlight positive aspects of ISRG, including outperforming market returns, bullish sentiment from Morgan Stanley, and recommendations from brokers.
*   **Innovation:** The unveiling of AI-powered da Vinci 5 upgrades is a significant positive development.
*   **Competition:** The mention of SS Innovations International, Inc. (SSII) indicates the presence of competition in the surgical robotics market.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (~1.94)
*   **Target Price:** Average: 580.10, High: 685.00, Low: 350.00
*   **Recent Rating Changes:** No information provided for recent rating changes

**Analysis:**

The analyst consensus is to "Buy" ISRG, with a significant upside potential based on the average target price.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-07-23 | 1.84 | 2.44 B$   |
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2024-07-19 | 1.48 | 2.01 B$   |
| 2025-07-23 | 1.48 | 2.01 B$   |

**Analysis:**

*   **EPS:** EPS has fluctuated, with the most recent value being 1.84.
*   **Revenue:** Revenue has generally increased over the period.

**6. Financial Information**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-06-30   | $2.44B    | 66.31%        |
| 2025-03-31   | $2.25B    | 64.69%        |
| 2024-12-31   | $2.41B    | 68.04%        |
| 2024-09-30   | $2.04B    | 67.41%        |
| 2024-06-30   | $2.01B    | 68.30%        |

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-06-30   | $17.85B   | 3.69%   |
| 2025-03-31   | $17.11B   | 4.08%   |
| 2024-12-31   | $16.43B   | 4.17%   |
| 2024-09-30   | $15.58B   | 3.63%   |
| 2024-06-30   | $14.71B   | 3.58%   |

**Analysis:**

*   **Revenue:** Revenue has shown a general upward trend.
*   **Profit Margin:** The profit margin has been relatively stable.
*   **Equity:** Equity has consistently increased.
*   **ROE:** ROE has fluctuated slightly.

**7. Overall Analysis**

ISRG exhibits a mixed picture. While it has underperformed the S&P 500 recently and has a relatively high RSI, it also shows positive signs:

*   **Strong Fundamentals:** Growing revenue, high profit margins, and increasing equity suggest a healthy underlying business.
*   **Positive Sentiment:** Analyst consensus is "Buy," and recent news highlights positive developments and bullish sentiment.
*   **Innovation:** Investment in AI-powered upgrades indicates a commitment to future growth.
*   **High Expected Return:** The high expected return suggests significant long-term upside potential, although the underperformance compared to the S&P 500 should be considered.
*   **MRI is High:** MRI 0.9 points to relatively lower risk.

**Recommendation:**

Based on the data, a cautious approach is warranted. While the long-term prospects appear positive, the recent underperformance and approaching overbought RSI suggest potential short-term headwinds. The Hybrid Signal recommends buying 2 shares of stock. Long-term investors might consider accumulating ISRG shares gradually, especially during pullbacks. However, it's crucial to consider the company's high volatility (as indicated by Beta) and competition from other surgical robotics companies.

***Disclaimer:** This analysis is based solely on the provided data and should not be considered financial advice. Always conduct thorough research and consult with a financial professional before making investment decisions.*
